Not found, error 404
The page you are looking for no longer exists. Perhaps you can return back to the site's homepage and see if you can find what you are looking for. Or, you can try finding it by using the search form below.
Sitemap
Pages:
- Administrative Assistant
- Aphios Granted Chinese Patent for Novel Bryoid to Treat Alzheimers Disease
- Cart
- Checkout
- Press Releases
- Aphios APH-1902 Drug Reduces Transplantation Injury and Improves Kidney Transplantation Efficiency
- Aphios Awarded an NIH Grant to Develop a Double Encapsulated mRNA Vaccine For COVID-19 and Other Diseases
- Aphios Awarded NIH Grant for Combination Therapeutic for Chronic Opioid Use Disorder Relapse
- Aphios CEO to Chair Roundtable Discussion on Transcytosis-Mediated Brain Delivery At HubXchange
- Aphios Granted CFI® Trademark for the Pathogen Reduction of Biologics, Human Plasma, Immunoglobulins and Viral Vaccines
- Aphios Granted US Patent for Novel, More Potent Bryoid to Treat CNS Diseases and Cancers
- Aphios Pharma LLC to Host Webinar on The Business of Cannabis as a Pharmaceutical Medicine
- Aphios Pharma LLC to Host Webinar on the Science and Technology of Cannabis as a Medicine
- Aphios to Present its Double-Encapsulated mRNA Vaccine at the 15th Annual Bioprocessing Summit
- Biotechnology Brings Microgravity Down to Earth – Manufacturing Picoparticles
- Dr. Trevor P. Castor Celebrated for Dedication to the Field of Business Management
- Newsweek Content Creator ‘Investment Reports’ Interviews Dr. Trevor P. Castor on The Future of Aphios and Biotechnology
- Thank You
- Virus-Free Convalescent Plasma
- Home
- Products
- Enhanced Therapeutic Products Overview
- Therapeutic Products Pipeline
- Research Chemicals & API’s
- Adhyperforin
- Adhyperforin dicyclohexylammonium salt (Adhyperforin DCHA)
- Betulin
- Betulinic Acid
- Bryostatin 1
- Bryostatin 2
- Bryostatin 3
- Camptothecin
- Carboxyatractyloside dipotassium salt (C-ATR)
- Cephalomannine
- Cyclopamine
- Cycloposine
- 10-deacetylbaccatin III (10-DAB)
- 9-dihydro-13-acetylbaccatin III (9-DHAB)
- Δ9-tetrahydrocannabinol (Δ9-THC)
- Frondoside A
- Δ9-Tetrahydrocannabinolic Acid (Δ9-THCA)
- 6-Gingerol
- 10-Gingerol
- 8-Gingerol
- Hyperforin
- Hypericin
- Hyperforin dicyclohexylammonium salt (Hyperforin DCHA)
- Jervine
- Methyllycaconitine citrate (MLA)
- Muldamine
- Nobiletin
- Paclitaxel
- Phloridzin Dihydrate
- Sclareolide
- 6-Shogaol
- Tangeretin
- Veratramine
- Equipment
- Quality of Life Medicines
- Technology
- Investors
- Partnering
- Resources
- About
- Company Overview
- Management & Directors
- Scientific Advisory Board
- Community Involvement
- Press Releases
- Aphios Awarded NIH Grant for Combination Therapeutic for Chronic Opioid Use Disorder Relapse
- Aphios Developing Pathogen Inactivation Technology for Biologics, Human Plasma, Immunoglobulins, Viral Vaccines
- Aphios Granted Chinese Patent For Novel Bryostatin To Treat Alzheimer’s Disease, HIV-1, Cancer
- Aphios Granted Hong Kong Patent for Compound to Treat Neurodegenerative diseases, Virus Latency, Cancer
- Aphios Granted United States Patent for Improved Delivery of Targeted siRNA Using Nanotechnology
- Aphios Granted Us Patent For Combination HIV Latency Nanoparticles Towards An HIV Cure
- Aphios Granted US Patent for Combination HIV Latency Nanotherapeutic Towards an HIV Cure
- Aphios Granted US Patent for Combination Therapeutic to Treat Neurodegenerative Diseases
- Aphios Granted US Patent for Novel, More Potent Bryoid to treat Alzheimer’s Diseases, HIV-1 Latency, Prostate Cancer, Glaucoma, and Multiple Sclerosis
- Aphios Granted US Patent for Oral Administration of Bryostatin-1 Nanoparticles for Treatment of Neurodegenerative Diseases
- Aphios Granted US Patent for Vitamin D3 Analog Nanoparticles for the Treatment of Prostate Cancer and Other Diseases
- Aphios International Launches Crowdfunding for Groundbreaking CFI Technology for Convalescent Plasma
- Aphios is Developing a Platform for the Delivery of siRNA-based Therapeutics Towards an HIV Cure
- Aphios is Developing Pathogen Inactivation Technology for Human Plasma Units
- Aphios Pharma LLC Announces Reg. CF Private Placement Offering
- Aphios Pharma LLC to Develop FDA-Approved, Cannabis-Based Drug for Opioid Addiction and other CNS Disorders
- Aphios Pharma LLC to Host Webinar on The Science and Technology of Cannabis as a Medicine
- Aphios Pharma to Develop FDA-Approved, Cannabis-Based Drugs for Opioid Addiction & CNS Disorders
- Oral Nanoparticle-Encapsulated Bryostatin-1 found Effective for Treating Cognitive Deficits in an Alzheimer’s Disease Mouse Model
- Press Releases Archive
- Aphios Granted Japanese Patent for Novel Bryostatins To Treat Alzheimer’s And Other Diseases
- Aphios Microgravity Bioscience Experiments On Pico Technology And Alzheimer’s Disease Scheduled For Launch On NG-11 To The International Space Station on April 17, 2019
- Aphios Granted European Patent For Novel Bryostatin To Treat Alzheimer’s Disease, HIV-1, And Cancers
- Events
- Careers
- Contact
- Shop
- Zindol® DS
- Product Information
- Historical Uses and Clinical Studies
- Pharmacology and Nonclinical Research
- Anti-Inflammatory and Analgesic Activities
- Anticancer Activity
- Antimicrobial Activity
- Antioxidant Effects
- Chemotherapy Induced Nausea and Vomiting (CINV)
- Effect on Blood Clotting
- Effect on Blood Pressure
- Effect on Gastrointestinal Tract
- Effect on Lipid and Glucose
- Motion Sickness Related Nausea and Vomiting (MRNV)
- Post-Operative Nausea and Vomiting
- Pregnancy Related Nausea and Vomiting (PRNV)
- Protection against Radiation Sickness
- Tissue and Radio-Protective Effects
- Potential Side Effects
- Zindol® DS Travel Size
- Sperol™ DS
- Cool Vitamin D™
- Xantol™ DS
- Zindol® DS
Categories:
Authors:
- Aphios (1)